Ed leads AstraZeneca’s commercial and scientific operations in Canada, including responsibility for the strategic direction and performance of the Canadian business.

Prior experience

Prior to his time at AstraZeneca, Ed led the Canadian establishment of Almirall, a start-up biopharmaceutical company focused on the treatment of respiratory diseases and affiliated with Almirall S.A., with headquarters in Barcelona, Spain. He worked for GlaxoSmithKline Inc. (GSK) for a total of  23 years in Canada in roles of increasing responsibility. Ed held a number of senior executive roles while at GSK, including Vice President of Marketing & Sales, and Vice President of Public Affairs and Reimbursement. Ed also held positions in marketing, product development and business development at Glaxo Wellcome Canada Inc. and Zeneca Pharma Inc.


  • Bachelor of Science in Toxicology, University of Toronto, Canada


  • Director on the Boards of both Innovative Medicines Canada and Life Sciences Ontario, organizations that represent and promote the vibrant and diverse health sciences sector
  • Serving as the Chair of the Acute Coronary Treatment (ACT) Foundation of Canada